Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Sucroferric oxyhydroxide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for sucroferric oxyhydroxide?

Sucroferric oxyhydroxide is the generic ingredient in one branded drug marketed by Vifor Fresenius and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has fifty-six patent family members in thirty-four countries.

There are two drug master file entries for sucroferric oxyhydroxide. One supplier is listed for this compound.

Summary for Generic Name: sucroferric oxyhydroxide

Tradenames:1
Patents:3
Applicants:1
NDAs:1
Drug Master File Entries: see list2
Suppliers / Packagers: see list1
Clinical Trials: see list2
Drug Prices:see low prices
DailyMed Link:sucroferric oxyhydroxide at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vifor Fresenius
VELPHORO
sucroferric oxyhydroxide
TABLET, CHEWABLE;ORAL205109-001Nov 27, 2013RXYesYes► Subscribe► Subscribe
Vifor Fresenius
VELPHORO
sucroferric oxyhydroxide
TABLET, CHEWABLE;ORAL205109-001Nov 27, 2013RXYesYes6,174,442► SubscribeY ► Subscribe
Vifor Fresenius
VELPHORO
sucroferric oxyhydroxide
TABLET, CHEWABLE;ORAL205109-001Nov 27, 2013RXYesYes9,561,251► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: sucroferric oxyhydroxide

Country Document Number Estimated Expiration
Norway982722► Subscribe
China104688702► Subscribe
Russian Federation2010124424► Subscribe
New Zealand585435► Subscribe
Luxembourg92626► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: SUCROFERRIC OXYHYDROXIDE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0018France► SubscribePRODUCT NAME: MELANGE D'OXYHYDROXYDE DE FER (III) POLYNUCLEAIRE,DE SACCHAROSE ET D'AMIDONS.; REGISTRATION NO/DATE: EU/1/14/943/001 20140826
2015 00007Denmark► SubscribePRODUCT NAME: BLANDING AF POLYNUKLEAERT JERN(III)-OXYHYDROXID, SUCROSE OG STIVELSE; REG. NO/DATE: EU/1/14/943/001-004 20140826
00710Netherlands► SubscribePRODUCT NAME: MENGSEL VAN POLYNUCLEAIRE IJZER (III)-OXYHYDROXIDE, SUCROSE EN ZETMEEL; REGISTRATION NO/DATE: EU/1/14/943 20140826
0868125/01Switzerland► SubscribePRODUCT NAME: FERRIOXYHYDROXIDUM/SACCHARUM/AMYLA; REGISTRATION NO/DATE: SWISSMEDIC 62986 22.01.2015
5Finland► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc